Open Access
CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd
DOI: 10.1055/a-2593-0275
GebFra Science
Review

Perinatal Neuroprotection in Preterm Birth

Article in several languages: English | deutsch
Richard Berger
1   Klinik für Gynäkologie und Geburtshilfe, Marienhaus Klinikum St. Elisabeth, Akademisches Lehrkrankenhaus der Universitäten Mainz und Maastricht, Neuwied, Germany (Ringgold ID: RIN39639)
,
Patrick Stelzl
2   Universitätsklinik für Gynäkologie, Geburtshilfe und gynäkologische Endokrinologie, Kepler Universitätsklinikum, Johannes Kepler Universität Linz, Linz, Austria (Ringgold ID: RIN31197)
,
3   Frauenklinik, Universitätsklinikum Rostock, Rostock, Germany (Ringgold ID: RIN39071)
,
4   Frauenkliniken, Asklepios Kliniken Barmbek, Wandsbek und Nord-Heidberg, Hamburg, Germany (Ringgold ID: RIN38169)
,
Angela Kribs
5   Kinderklinik, Abteilung für Neonatologie, Universitätsklinikum Köln, Köln, Germany (Ringgold ID: RIN27182)
,
Holger Maul
4   Frauenkliniken, Asklepios Kliniken Barmbek, Wandsbek und Nord-Heidberg, Hamburg, Germany (Ringgold ID: RIN38169)
› Author Affiliations
Preview

Abstract

Preterm birth is one of the main causes of perinatal morbidity and mortality. The rate of grade III and IV cerebral hemorrhages in infants with a birth weight of less than 1500 g in Germany in 2022 was 2.97% and the periventricular leukomalacia rate was 1.07%. In addition to these severe forms of brain damage which are visible on sonography, recent MRI studies carried out at the calculated due date of affected children also showed diffuse white and grey matter injuries, especially of the basal ganglia and the cerebellum, indicating impaired brain development and function. To offer these children the best possible start in life it is essential that they are cared for in a level I perinatal center right from the start. In addition, a number of perinatal measures are available which may significantly improve the neuronal development in preterm infants. They include the use of antenatal corticosteroids and magnesium as well as deferred cutting of the umbilical cord. Recent studies have shown that in contrast to term-born infants, hypothermia treatment is unsuitable for neuroprotection in premature babies. As secondary and tertiary cell damage may occur days or even weeks after the primary insult due to persistent inflammation and the lack of trophic stimulation, in addition to providing premature infants with the best possible initial care, it is also necessary to optimize subsequent care in the intensive care unit in terms of providing a neuronal-positive stimulating environment. Breastfeeding and supply of breast milk are particularly important in this context.



Publication History

Received: 23 January 2025

Accepted after revision: 12 March 2025

Article published online:
30 June 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany